Does using ethnic specific criteria improve the usefulness of the term metabolic syndrome? Controversies and suggestions (Q36793612)

16 August 2017

1 reference

title

Does using ethnic specific criteria improve the usefulness of the term metabolic syndrome? Controversies and suggestions (English)

1 reference

16 August 2017

1 reference

Banerjee D

1

1 reference

16 August 2017

Misra A

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

17 April 2007

1 reference

International Journal of Obesity

16 August 2017

published in

1 reference

16 August 2017

volume

31

1 reference

16 August 2017

issue

9

1 reference

16 August 2017

page(s)

1340-1349

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ijo.0803619

16 August 2017

exact match

0 references

cites work

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men--the Tanno and Sobetsu Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Insulin resistance alone does not explain the clustering of cardiovascular risk factors in southern India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Emerging epidemic of cardiovascular disease in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindian and Mixed Hispanics in Zulia State, Venezuela

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

The prevalence of the metabolic syndrome among arab americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Primordial prevention of coronary heart disease in India: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Coronary heart disease mortality for six ethnic groups in California, 1990-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

The Metabolic Syndrome in Asian Indians: Impact of Nutritional and Socio-economic Transition in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Obesity: impact of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Non-obese (body mass index < 25 kg/m2) Asian Indians with normal waist circumference have high cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Prevalence of the metabolic syndrome using the Third Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) and the modified ATP III definitions for J

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Appropriate BMI for Asian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Body mass index, waist circumference, waist-hip ratio, and glucose intolerance in Chinese and Europid adults in Newcastle, UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Prevalence and magnitude of classical risk factors for coronary heart disease in a cohort of 4400 Chinese steelworkers over 13.5 years follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Subclinical coronary atherosclerosis in asymptomatic Filipino and white women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Ethnicity and cardiovascular risk: variations in people of African ancestry and South Asian origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Racial variation in cardiovascular morbidity and mortality in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

LDL size in African Americans, Hispanics, and non-Hispanic whites : the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Associations of diabetes mellitus and ethnicity with mortality in a multiethnic Asian population: data from the 1992 Singapore National Health Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Homeostasis model assessment in a population with mixed ethnicity: the 1992 Singapore National Health Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Does ethnic origin have an independent impact on hypertension and diabetic complications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

(Mis)use of factor analysis in the study of insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Race/ethnic issues in obesity and obesity-related comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

An evaluation of candidate definitions of the metabolic syndrome in adult Asian Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Acanthosis nigricans associated with insulin resistance : pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

C-reactive protein level as an independent risk factor of metabolic syndrome in the Korean population. CRP as risk factor of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Ethnicity and Cardiovascular Disease: The incidence of myocardial infarction in white, South Asian, and Afro-Caribbean patients with type 2 diabetes (U.K. Prospective Diabetes Study 32)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

Leptin and other components of the Metabolic Syndrome in Mauritius—a factor analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

7 January 2021

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

7 January 2021

Obesity : impact on cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

7 January 2021

The relationship between insulin resistance and cardiovascular risk factors in overweight/obese non-diabetic Asian adults: the 1992 Singapore National Health Survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

7 January 2021

The effect of decision rules on the choice of a body mass index cutoff for obesity: examples from African American and white women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

7 January 2021

Revisions of cutoffs of body mass index to define overweight and obesity are needed for the Asian-ethnic groups

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

7 January 2021

Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803619

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0803619

1 reference

16 August 2017

1 reference